Digital Oncology Cross Topic @ DKFZ

@digitaloncology.bsky.social

We are Data Scientists & Architects in Cancer Research. The German Cancer Research Center is matrix structured, with 5 research topics & cross topics. Our cross topic boosts cancer research by driving next level AI methods & data science in all domains.

AI can help classify brain tumors in minutes instead of weeks: Moritz Gerstung & collaborators have developed Hetairos, an AI system that identifies 102 molecular brain tumor subtypes from routine tissue sections ~12 minutes after digitization. 📰Now out in Nature Cancer! www.dkfz.de/en/news/pres...

AI Diagnoses Brain Tumors in Minutes Instead of Weeks

Experts in Heidelberg have developed an AI system that can classify brain tumors with unprecedented accuracy using standard microscopic tissue sections. Using digitized standard stains, the system ide...

dkfz.de

The next talk in the #AIinLife Seminar Series is hosted @dkfz.bsky.social! Come meet the speaker at TP3 in Heidelberg!

ELLIS Unit Heidelberg@ellisheidelberg.bsky.social · 4mo ago

Up next is another great talk as part of our #AIinLife Seminar Series: 💡 Clinical Risk Scores, Causality & Competing Events with Autoregressive Transformers 🧠 Rajesh Ranganath (NYU) 📍 DKFZ Heidelberg - TP3 or Zoom 📅 19 June 2026 | 11:00 CET 🔗 More information: www.ai-life-delta.com/news-events-...

Interested in working at the intersection of #data, #AI & #cancer research? The DKFZ International PhD Program is hiring! From a Digital Oncology perspective, we’re especially interested in candidates who want to apply computational & data-driven approaches to oncology. 👉 apply here: t1p.de/hl56b

DKFZ International PhD Program - German Cancer Research Center

t1p.de

Deutsches Krebsforschungszentrum (DKFZ)@dkfz.bsky.social · 6mo ago

Dreaming of a career in cancer research? Join the International PhD Program at DKFZ - Germany’s largest biomedical research center. Explore #cancerresearch including #cancerbiology, #bioinformatics, #epidemiology & #medicalphysics. The Summer Selection is open now 👉 apply here: t1p.de/hl56b

great interview - worth watching the linked video 🎬! Happy to have @moritzgerstung.bsky.social on the board of the Digital Oncology Cross Topic, where he helps shape and strengthen AI research in oncology beyond his own working group @dkfz.bsky.social.

EMBL-EBI@ebi.embl.org · 9mo ago

From showing that leukemia is 11 different diseases to developing an AI that can predict the risks of 1000 diseases, our alumnus @moritzgerstung.bsky.social is pushing the boundaries of AI and bioinformatics. www.ebi.ac.uk/about/news/p...

Fresh off the press in 2026! Interested in the challenge of how to advance from descriptive atlases to causal mechanisms and counterfactuals? 🔬 Take a look at our recent perspective: "Interpretation, extrapolation and perturbation of single cells"! (rdcu.be/eXeDY)

Interpretation, extrapolation and perturbation of single cells

Nature Reviews Genetics - Causal and mechanistic modelling strategies, which aim to infer cause–effect relationships, provide insights into cellular responses to perturbations. The authors...

rdcu.be

We’re thrilled to welcome Yuki Asano, Professor at the University of Technology Nuremberg and head of the Fundamental AI (FunAI) Lab, to our heidelberg.ai / NCT Data Science Seminar series on May 13th at 5 pm in Heidelberg (INF280 Seminar Rooms K1+K2) for an in-person event.

Bild

🚠 #AI in Altitude - a high-flying start for Digital Oncology@DKFZ with NCT & DKTK partners! We gathered at the scenic Königstuhl for a retreat packed with energy, ideas & collaboration. From AI for data management to a translation task force, lots of science & strategy: excited for what’s ahead!💡🧠💻

Bild